...
首页> 外文期刊>Pharmacogenomics >Research Highlights Highlights from the latest research in mood disorder pharmacogenomics
【24h】

Research Highlights Highlights from the latest research in mood disorder pharmacogenomics

机译:研究要点来自情绪障碍药物基因组学最新研究的要点

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To date, lithium salts represent the first-choice treatment for bipolar disorder.Although clinical lithium efficacy has been widely demonstrated, the exact biochemical mechanisms that underlie the clinical effects of this drug remain only partially unraveled. The most important question is related to the latency in the initiation of the mood stabilization effect of lithium, which is classically delayed for weeks or months, suggesting that the therapeutic effects of this salt could result from neu-ronal modifications, controlled by a pool of late response genes.
机译:迄今为止,锂盐代表了双相情感障碍的首选治疗方法。尽管临床锂功效已得到广泛证明,但仍不能部分阐明该药临床疗效的确切生化机制。最重要的问题与锂的情绪稳定作用开始的潜伏期有关,这通常会延迟数周或数月,这表明该盐的治疗作用可能是由神经元修饰引起的,受神经元修饰的控制。晚期反应基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号